In an advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) recently granted clearance for an Alzheimer’s disease blood test. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.